🛬 Airlines hit turbulence

+ Judge says no deal to J&J $10B settlement, Rogers' $11B NHL deal raises eyebrows, and more

Good evening. Trump announced he's cancelling all tariffs and embracing global free trade… April Fools! In reality, US stocks stayed rocky today as investors waited for more clarity ahead of Trump’s big “Liberation Day” tomorrow.

Nasdaq
⬆︎0.24%

S&P 500
⬆︎0.38%

Dow Jones
⬇︎0.03%

⬆︎⬇︎ 1-day change
Market data: today’s market close

WINNERS

⬆︎18.08% PVH

🛎️ Earnings report - The fashion giant behind Calvin Klein and Tommy Hilfiger beat expectations, gave a bright outlook, and announced plans to repurchase $500 million of its own stock. And when a company invests in itself, investors tend to follow. (Investopedia)

⬆︎5.08% Hims & Hers

Hims & Hers will start offering Eli Lilly’s weight-loss drug Zepbound on its platform. The company had been selling a custom-made version of a similar drug, but when the FDA said the original version was no longer in short supply, Hims suffered. This new move helps the company stay in the fast-growing weight-loss business. (Sherwood News)

⬆︎⬇︎ 1-day change
Market data: today’s market close

LOSERS

⬇︎2.91% Intel

Intel’s new CEO, Lip-Bu Tan, said at the company's Intel Vision 2025 conference that he wants the struggling chipmaker to act more like a startup and focus on its core business. But analysts were hoping for more substance and fewer broad statements. Tan has only been in the job two weeks. (IBD)

⬇︎5.88% Rogers

The Canadian telecom giant is renewing its NHL broadcast deal for $11 billion—more than double its last agreement in 2013. Investors are worried about the cost and how it could strain the company’s already tight finances. Separately, the stock caught a downgrade from an analyst, citing the costs of running its Rogers Mastercard. (BNN Bloomberg)

⬇︎6.04% Southwest

Turbulence ahead for airline stocks. A Jefferies analyst just downgraded Southwest’s stock, among other airlines, warning that soft demand and economic uncertainty could hurt earnings this year. Consumers and companies are pulling back on travel, and with new tariffs looming, things could get even bumpier. (Gurufocus)

⬇︎7.59% Johnson & Johnson

A judge rejected a $10 billion plan to settle thousands of lawsuits claiming its talc-based baby powder caused cancer. The court said the pharma giant isn’t in financial trouble and can’t use bankruptcy to resolve the claims. (Yahoo)

⬆︎⬇︎ 1-day change
Market data: today’s market close

EXTRA

STOCKTWITS

THE END

That’s it for today’s recap. We hope you found it valuable.

  • Have any feedback? We’d love to hear from you—just reply to this email.

  • Was this email forwarded to you? Subscribe to our newsletter so you can stay updated on stock movers every day.

  • Missed our previous newsletters? You can catch up on them here.

  • Interested in advertising with us? Reply to this email, and we’ll take it from there.

  • Be part of the conversation on our subreddit.